UBS is holding firm on its Buy rating and $1,050 price target for Eli Lilly, driven by faith in the upcoming SURPASS-CVOT ...

Trulicity sales were $5.46 billion in the first nine months of 2023 - a slight decline on the same period of 2022 that Lilly said was down to shortages, as well as increased competition in the market.

Shares in Eli Lilly have weakened after CVS Health, one of the largest pharmacy benefit managers (PBMs) in the US, said it would no longer cover its obesity therapy Zepbound. The shares closed ...

Some men on social media claimed that their penis size increased after taking Ozempic (semaglutide). This effect might have more to do with weight loss rather than the medication itself. Why Might ...